Farmaten International S.A. (manufacturing, primary and secondary packaging, batch control)

The drug is prescribed for monotherapy in adults and children aged 10 years and older with highly active relapsing-remitting multiple sclerosis. This applies to patients who have not responded to previous treatment or those experiencing frequent exacerbations or new lesions on MRI.

Dosage form: capsules, hard

ATC: L04AE01